Osmotic pressure regulates alpha beta gamma-rENaC expressed in Xenopus oocytes.
The hypothesis that amiloride-sensitive Na+ channels (ENaC) are involved in cell volume regulation was tested. Anisosmotic ND-20 media (ranging from 70 to 450 mosM) were used to superfuse Xenopus oocytes expressing alpha beta gamma-rat ENaC (alpha beta gamma-rENaC). Whole cell currents were reversibly dependent on external osmolarity. Under conditions of swelling (70 mosM) or shrinkage (450 mosM), current amplitude decreased and increased, respectively. In contrast, there was no change in current amplitude of H2O-injected oocytes to the above osmotic insults. Currents recorded from alpha beta gamma-rENaC-injected oocytes were not sensitive to external Cl- concentration or to the K+ channel inhibitor BaCl2. They were sensitive to amiloride. The concentration of amiloride necessary to inhibit one-half of the maximal rENaC current expressed in oocytes (Ki; apparent dissociation constant) decreased in swollen cells and increased in shrunken oocytes. The osmotic pressure-induced Na+ currents showed properties similar to those of stretch-activated channels, including inhibition by Gd3+ and La3+, and decreased selectivity for Na+. alpha beta gamma-rENaC-expressing oocytes maintained a nearly constant cell volume in hypertonic ND-20. The present study is the first demonstration that alpha beta gamma-rENaC heterologously expressed in Xenopus oocytes may contribute to oocyte volume regulation following shrinkage.
Ji
H L
HL
Department of Physiology and Biophysics, University of Alabama, Birmingham, Alabama 35294-0005, USA.
Fuller
C M
CM
Benos
D J
DJ
D000584:Amiloride / Q000494:pharmacology; D000818:Animals; D017609:Barium Compounds / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D053503:Epithelial Sodium Channels; D005260:Female; D006706:Homeostasis; D006982:Hypertonic Solutions; D007038:Hypotonic Solutions; D066298:In Vitro Techniques; D046911:Macromolecular Substances; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D009865:Oocytes / Q000187:drug effects / Q000502:physiology; D009994:Osmolar Concentration; D009997:Osmotic Pressure; D051381:Rats; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000378:metabolism; D015222:Sodium Channels / Q000096:biosynthesis / Q000502:physiology*; D014981:Xenopus
D017609:Barium Compounds; D002712:Chlorides; D053503:Epithelial Sodium Channels; D006982:Hypertonic Solutions; D007038:Hypotonic Solutions; D046911:Macromolecular Substances; D011994:Recombinant Proteins; D015222:Sodium Channels; C024986:barium chloride; D000584:Amiloride